Response rate, PFS, and TAM phenotype by quality of response. (A) Response rates at each time point. (B) PFS by CR vs PR (data confirmed in a landmark analysis at 21 months). (C) CD163⁺ TAM density by CR vs PR. CI, confidence interval; HR, hazard ratio; PD, progressive disease; SD, stable disease.